ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg".
Announcement as on 09 April 2026

Company Announcement
Glenmark Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Announcement as on 06 April 2026

Company Announcement
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expand
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325.
Announcement as on 23 March 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2369.7
  • 12Day Average: 2303.73
  • 20Day Average: 2237.77
  • 50Day Average: 2164.73
  • 100Day Average: 2078.55
  • 150Day Average: 2019.98
  • 200Day Average: 2030.59

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2313.38, 2245.81, 49.55
Indicator MACD is in positive zone

Indicator ADX (14)

43.1, 33.34, 13.26
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Thu Apr 2026 2406.30 2385.60 to 2455.90 -0.31% 1.14 times
29 Wed Apr 2026 2413.90 2403.70 to 2474.00 0.42% 0.89 times
28 Tue Apr 2026 2403.70 2327.30 to 2427.40 3.38% 2.21 times
27 Mon Apr 2026 2325.10 2290.90 to 2339.90 1.11% 0.67 times
24 Fri Apr 2026 2299.50 2283.20 to 2372.80 -1.52% 1.21 times
23 Thu Apr 2026 2335.00 2212.10 to 2359.40 4.24% 2.45 times
22 Wed Apr 2026 2240.00 2204.80 to 2247.00 0.31% 0.47 times
21 Tue Apr 2026 2233.10 2215.20 to 2245.00 0.11% 0.37 times
20 Mon Apr 2026 2230.70 2210.50 to 2250.50 -0.84% 0.59 times
17 Fri Apr 2026 2249.50 2240.90 to 2274.90 0% 0.53 times
16 Thu Apr 2026 2249.50 2228.60 to 2273.80 -0.39% 0.63 times
15 Wed Apr 2026 2258.40 2205.00 to 2265.00 2.98% 0.89 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top